123 related articles for article (PubMed ID: 15081893)
1. Inhibition of fucosyltransferase VII by gallic acid and its derivatives.
Niu X; Fan X; Sun J; Ting P; Narula S; Lundell D
Arch Biochem Biophys; 2004 May; 425(1):51-7. PubMed ID: 15081893
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
[TBL] [Abstract][Full Text] [Related]
3. Study of the release of gallic acid from (-)-epigallocatechin gallate in old oolong tea by mass spectrometry.
Lee RJ; Lee VS; Tzen JT; Lee MR
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):851-8. PubMed ID: 20201026
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate.
Baek WK; Jang BC; Lim JH; Kwon TK; Lee HY; Cho CH; Kim DK; Shin DH; Park JG; Lim JG; Bae JH; Bae JH; Yoo SK; Park WK; Song DK
Biochem Pharmacol; 2005 Nov; 70(11):1560-7. PubMed ID: 16216226
[TBL] [Abstract][Full Text] [Related]
5. Changes in amino acid pool and utilization during apoptosis in HL-60 cells induced by epigallocatechin gallate or gallic acid.
Sakagami H; Yokote Y; Akahane K
Anticancer Res; 2001; 21(4A):2441-7. PubMed ID: 11724305
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of catechin- and theaflavin-mediated cardioprotection.
Dreger H; Lorenz M; Kehrer A; Baumann G; Stangl K; Stangl V
Exp Biol Med (Maywood); 2008 Apr; 233(4):427-33. PubMed ID: 18367631
[TBL] [Abstract][Full Text] [Related]
7. Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase.
Wang X; Tian W
Biochem Biophys Res Commun; 2001 Nov; 288(5):1200-6. PubMed ID: 11700039
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
Banerjee T; Sharma SK; Surolia N; Surolia A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
[TBL] [Abstract][Full Text] [Related]
9. Highly sensitive cell-based assay system to monitor the sialyl Lewis X biosynthesis mediated by alpha1-3 fucosyltransferase-VII.
Miyashiro M; Furuya S; Fujishige K; Sugita T
Biochem Biophys Res Commun; 2004 Nov; 324(1):98-107. PubMed ID: 15464988
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the biological activities of methylated derivatives of (-)-epigallocatechin-3-O-gallate (EGCG) and their cell surface binding activities.
Yano S; Fujimura Y; Umeda D; Miyase T; Yamada K; Tachibana H
J Agric Food Chem; 2007 Aug; 55(17):7144-8. PubMed ID: 17661493
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate.
Dodo K; Minato T; Noguchi-Yachide T; Suganuma M; Hashimoto Y
Bioorg Med Chem; 2008 Sep; 16(17):7975-82. PubMed ID: 18693020
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
[TBL] [Abstract][Full Text] [Related]
14. Inactivation mechanism of the beta-ketoacyl-[acyl carrier protein] reductase of bacterial type-II fatty acid synthase by epigallocatechin gallate.
Li BH; Zhang R; Du YT; Sun YH; Tian WX
Biochem Cell Biol; 2006 Oct; 84(5):755-62. PubMed ID: 17167539
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate.
Jackson JK; Zhao J; Wong W; Burt HM
J Mater Sci Mater Med; 2010 May; 21(5):1435-43. PubMed ID: 20162329
[TBL] [Abstract][Full Text] [Related]
16. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
[TBL] [Abstract][Full Text] [Related]
17. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
18. Alpha 1,3-fucosyltransferase-VII regulates the signaling molecules of the insulin receptor pathway.
Wang QY; Zhang Y; Chen HJ; Shen ZH; Chen HL
FEBS J; 2007 Jan; 274(2):526-38. PubMed ID: 17229154
[TBL] [Abstract][Full Text] [Related]
19. Antioxidative galloyl esters as enzyme inhibitors of p-hydroxybenzoate hydroxylase.
Abe I; Kashiwagi K; Noguchi H
FEBS Lett; 2000 Oct; 483(2-3):131-4. PubMed ID: 11042267
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors.
Mizushina Y; Saito A; Tanaka A; Nakajima N; Kuriyama I; Takemura M; Takeuchi T; Sugawara F; Yoshida H
Biochem Biophys Res Commun; 2005 Jul; 333(1):101-9. PubMed ID: 15950188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
